Independent Proxy Advisory Firm Glass Lewis Approves RIV Capital Board of Directors

  • Independent proxy advisory firm Glass Lewis recommends that shareholders vote FOR highly qualified nominees to RIV Capital’s board of directors.
  • The visionary and highly experienced nominees of RIV Capital’s Board of Directors bring diverse opinions, financial and capital markets experience, and an understanding of the cannabis market in both Canada and the United States; they are committed to generating future growth and further enhancing shareholder value.
  • Vote FOR RIV Capital Board Nominees Well Before the Deadline 10:00 a.m. (EDT) on September 27, 2022. For assistance in voting, please contact Kingsdale Advisors at 1-877-659-1821 (toll-free in North America), or at 1-416-867-2272 (to be collected outside North America), or by email at [email protected].

TORONTO, September 7, 2022 /PRNewswire/ – RIV Capital Inc. (“Capital of RIV“or the”Company“) (CSE:RIV) (OTC:CNPOF), an acquisition and investment firm focused on building a leading multi-state platform with the strongest portfolio of cannabis brands in markets key strategies through United Statesannounced today that a leading proxy advisory firm, Glass, Lewis & Co. (“Lewis glass“), recommended that RIV Capital shareholders vote FOR the seven members of the Company’s Board of Directors (the “Plank“) nominees – Laura Curran, Chris Hagedorn, Richard Mavrinac, Joseph Mimran, Amy Peckham, Tag Sims and Dawn Sweeney.

Nominees to RIV Capital’s Board of Directors are highly qualified individuals with relevant industry expertise who are committed to ensuring future growth and further enhancing shareholder value. To learn more about each candidate, visit

“Glass Lewis’s recommendation to shareholders to vote FOR our board nominees is further evidence that the company is on the right track and is well positioned to become a leading cannabis operator,” said Tag SimsDirector, President and Chief Executive Officer, Capital of RIV. “We strongly believe that our director nominees will provide RIV Capital with the right balance of continuity and fresh perspectives, relevant experience, strategic vision and bold, forward-looking ideas that the company needs to create a significant shareholder value in the years to come. »

Vote FOR RIV Capital Board Nominees Today
Shareholders are encouraged to vote well in advance of the deadline for 10:00 a.m. (EDT) on September 27, 2022.

Voting is quick and easy – if you have any questions or need help voting, contact Kingsdale Advisors at 1-877-659-1821 (toll-free in North America), or at 1-416-867-2272 (to be collected outside North America), or by email at [email protected].

About RIV Capital

Capital of RIV is building a leading packaged cannabis business, with a focus on establishing one of the strongest brand portfolios in key strategic markets in the United States. Leveraging its in-house expertise and knowledge of the cannabis space, RIV Capital aims to grow its own brands and partner with established US cannabis operators and brands to take them to new markets and gain market share. market. RIV Capital laid the foundations of its active US strategy with the previously announced acquisition of Etain. Through its strategic relationship with The Hawthorne Collective, Inc. (“The Hawthorne Collective“), a subsidiary of ScottsMiracle-Gro, RIV Capital is The Hawthorne Collective’s preferred vehicle for cannabis-related investments not covered by other ScottsMiracle-Gro subsidiaries.

Forward-looking statements

This press release contains statements that constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the current plans, intentions, beliefs and expectations of RIV Capital and its portfolio companies. regarding future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, ” believes”, “expects” or similar expressions and includes information about of the company strategies, objectives, goals, opportunities and plans, including with respect to future growth and creation of shareholder value; and expectations regarding other economic, business and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical fact but rather reflects management’s expectations, estimates or projections regarding future results or events based on management’s opinions, assumptions and estimates believed to be reasonable at the date on which the declarations are made. Although RIV Capital believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of RIV Capital or its portfolio companies.

Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are: the timing and likelihood of receipt of all required regulatory approvals, and satisfaction of other closing conditions, with respect to Tin Acquisition; the Company’s ability to execute its future strategy; stock market volatility; changes in the business activities, direction and plans of the Company, Etain and the Company’s investees and the timing associated therewith; the timing of any changes to federal laws in the United States to permit the general cultivation, distribution and possession of cannabis; regulatory and licensing risks; changes in the growth and trends of the cannabis industry; changes in general economic, business and political conditions, including changes in financial markets; litigation risks; the global regulatory landscape and law enforcement related to cannabis, including political risks and risks related to regulatory changes; risks related to anti-money laundering laws; compliance with extensive governmental regulations, including RIV Capital’s interpretation of such regulations; public opinion and perception of the cannabis industry; disposal risks; and the risk factors set out in RIV Capital’s management report dated August 29, 2022 and annual information form dated June 10, 2022 filed with the Canadian securities authorities and available on RIV Capital’s profile on SEDAR at

The Company has invested in and acquired, and intends to invest and/or acquire in the future, businesses involved in the manufacture, possession, use, sale and distribution of cannabis in the market recreational and medical cannabis in United States. Local laws in the states where such operations take place permit such activities, however, investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in United States for, among other things, cultivating, distributing or possessing cannabis in United States. Financial transactions involving proceeds generated by, or intended to promote, commercial activities related to cannabis in United States may form the basis of prosecution under applicable US federal money laundering laws.

Although the federal government’s approach to enforcing these laws in United States tends not to enforce laws against individuals and businesses that comply with recreational and medical cannabis programs in states where such programs are legal, strict compliance with state cannabis laws will not exonerate the Company from liability under US federal law, nor will it provide a defense to any federal proceeding that may be brought against the Company. The application of federal laws in United States poses a significant risk to the Company’s business and any legal action brought against the Company under this provision could adversely affect the Company’s business and financial performance.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may differ materially from those described herein as anticipated, planned, anticipated, believed, estimated or expected. Although RIV Capital has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be those anticipated, estimated or planned. RIV Capital does not intend and undertakes no obligation to update this forward-looking information, except as otherwise required by applicable law.

SOURCE RIV Capital Inc.

About Dwayne Wakefield

Check Also

Glass Syringes Market Size | Trends | Growth | Range until 2028

“The Market research intelligence has added a new statistical market report to its repository titled …